IL-12-releasing nanoparticles for effective immunotherapy of metastatic ovarian cancer.

Nat Mater · 2026 · PMC12867765 · PMID 41174039

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In tumour nodules, both free IL-12 and Mal LbL NPs showed a trend towards reduced Tregs, which were ~10% of T cells in dextrose-treated mice (Extended Data Fig. 9f ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.